We further analysed the effects of GATA5 on the β‐catenin signalling pathway transduction in HCC cells using siRNA‐GATA5 and the signalling pathway inhibitor salinomycin (Sali). This evidence concerns the gene GATA5 and hepatocellular carcinoma.